Curexo’s DigiMatch Robodoc
This article was originally published in The Gray Sheet
Executive Summary
Image-directed robotic surgical system gains 510(k) clearance to prepare hip joints for replacement. The system allows surgeons to select "an ideal implant from multiple implant manufacturers after reviewing a detailed CT scan," Curexo says. Robodoc is the first active robotic system cleared for orthopedic surgery, the Sacramento, Calif., company claims. Curexo acquired the technology in 2007 with the assets of Integrated Surgical Systems
You may also be interested in...
Robotic knee surgery
Curexo Technology submits 510(k) application for use of its Robodoc robotic surgical system to prepare knee joints for replacement. Robodoc allows surgeons to preoperatively plan total knee arthroplasty procedures in a 3-D virtual space and then perform the surgery exactly as planned on the patient's knee. The robotic surgical system gained 510(k) clearance for use in total hip arthroplasty in August and has been used in over 24,000 surgical procedures worldwide to date (1"The Gray Sheet" Aug. 25, 2008, In Brief)
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.